Atria Investments Inc Grows Holdings in Globe Life Inc. $GL

Atria Investments Inc increased its stake in Globe Life Inc. (NYSE:GL) by 97.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,135 shares of the company’s stock after buying an additional 6,470 shares during the period. Atria Investments Inc’s holdings in Globe Life were worth $1,878,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Globe Life by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock worth $1,237,000 after purchasing an additional 607 shares during the last quarter. NewEdge Advisors LLC raised its stake in Globe Life by 368.1% during the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after buying an additional 5,352 shares in the last quarter. Goldman Sachs Group Inc. grew its position in shares of Globe Life by 11.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock worth $74,161,000 after acquiring an additional 58,163 shares in the last quarter. Empowered Funds LLC bought a new stake in shares of Globe Life in the 1st quarter valued at approximately $428,000. Finally, Focus Partners Wealth raised its position in shares of Globe Life by 8.3% during the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after acquiring an additional 656 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors.

Globe Life Price Performance

NYSE:GL opened at $146.00 on Wednesday. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life Inc. has a one year low of $109.38 and a one year high of $152.71. The company has a fifty day moving average price of $141.06 and a 200 day moving average price of $138.48. The stock has a market cap of $11.62 billion, a P/E ratio of 10.37 and a beta of 0.47.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The firm had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period last year, the business earned $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current year.

Insider Buying and Selling at Globe Life

In related news, Director Mark A. Blinn sold 1,750 shares of the company’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $147.91, for a total value of $258,842.50. Following the sale, the director owned 3,372 shares of the company’s stock, valued at $498,752.52. The trade was a 34.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Frank M. Svoboda sold 9,379 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total value of $1,317,092.97. Following the completion of the sale, the chief executive officer owned 35,868 shares in the company, valued at approximately $5,036,943.24. This represents a 20.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 51,129 shares of company stock worth $7,414,035. Corporate insiders own 1.97% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on GL shares. Keefe, Bruyette & Woods raised their price target on shares of Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 28th. Truist Financial lifted their price objective on shares of Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research note on Friday, February 6th. JPMorgan Chase & Co. increased their target price on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. TD Cowen reissued a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Finally, Wells Fargo & Company decreased their price objective on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Eight analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Globe Life currently has a consensus rating of “Moderate Buy” and an average price target of $171.00.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.